CTLA4 and breast cancer: Blood serum analysis after implantation showed that BC significantly reduced IgG as well as anti-CTLA-4 peak levels, as compared to mice that received IgG in free solution (more than 5-fold), which is a considerable factor of decrease in cancer drug delivery studies.